Because Sema3A is known to act in such a manner, at least in development, and it was already reported to be elevated in ALS, we decided to focus on this factor (De Winter et al., 2006; Körner et al., 2016). This evidence concerns the gene SEMA3A and amyotrophic lateral sclerosis.